The stock gained 3.3% following a solid quarter marked by better-than-expected growth and profitability, driven by record operating profit in P&C and strong results in Asset Management. The market rewarded the company’s resilience and execution despite ongoing macroeconomic uncertainty.

• Operating profit rose nearly 7% year-on-year, led by a double-digit increase in P&C reaching a new record level and a 6% (15% FX-adjusted) rise in Asset Management profits.
• P&C volume grew internally by 7%, split evenly between price and volume, with a combined ratio of 91%, reflecting strong underwriting profitability and improved expense management.
• Life & Health business showed resilience; new business volumes were slightly up when adjusting for prior-year high comparables, FX, and disposals, with attractive product mix and normalized Life CSM growth of 1.7%.
• Core net income, excluding the one-time EUR 1.1 billion Bajaj disposal gain, rose 7%, with return on equity at 18% and EPS growth of 9%, indicating solid underlying earnings momentum.
• The Solvency II ratio remained strong at 221%, evidencing robust capital generation and risk resilience amid market volatility.